Paper42220006
Complementary ROC-Derived Indices for Screening Improper Expression Profiles in RNA-Seq Differential Expression Analysis.
Başol Göksülük M and 5 others. Balkan Med J, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Complementary ROC-Derived Indices for Screening Improper Expression Profiles in RNA-Seq Differential Expression Analysis. Papers, record 42220006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42220006
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Complementary ROC-Derived Indices for Screening Improper Expression Profiles in RNA-Seq Differential Expression Analysis.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ROC Curve | Major topic |
| Gene Expression Profiling | Major topic |
| Sequence Analysis, RNA | Major topic |
| RNA-Seq | Major topic |
| Humans | |
| Area Under Curve |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28476144 | Multi-omics approaches to disease. | Genome Biol | 2017 | https://conductscience.org/library/papers/28476144 | PubMed |
| 2 | 30943822 | Effect of miR-301a/PTEN pathway on the proliferation and apoptosis of cervical cancer. | Innate Immun | 2019 | https://conductscience.org/library/papers/30943822 | PubMed |
| 3 | 38286198 | Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis. | Cell Signal | 2024 | https://conductscience.org/library/papers/38286198 | PubMed |
| 4 | 25516281 | Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. | Genome Biol | 2014 | https://conductscience.org/library/papers/25516281 | PubMed |
| 5 | 23303507 | SIBER: systematic identification of bimodally expressed genes using RNAseq data. | Bioinformatics | 2013 | https://conductscience.org/library/papers/23303507 | PubMed |
| 6 | 19718451 | The bimodality index: a criterion for discovering and ranking bimodal signatures from cancer gene expression profiling data. | Cancer Inform | 2009 | https://conductscience.org/library/papers/19718451 | PubMed |
| 7 | 34298978 | The Role of microRNA Let-7d in Female Malignancies and Diseases of the Female Reproductive Tract. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34298978 | PubMed |
| 8 | 34384574 | Computational methods to identify bimodal gene expression and facilitate personalized treatment in cancer patients. | J Biomed Inform | 2019 | https://conductscience.org/library/papers/34384574 | PubMed |
| 9 | 34258298 | LINC00707 Regulates miR-382-5p/VEGFA Pathway to Enhance Cervical Cancer Progression. | J Immunol Res | 2021 | https://conductscience.org/library/papers/34258298 | PubMed |
| 10 | 36908850 | miR-19-3p Targets PTEN to Regulate Cervical Cancer Cell Proliferation, Invasion, and Autophagy. | Genet Res (Camb) | 2023 | https://conductscience.org/library/papers/36908850 | PubMed |
| 11 | 35639779 | Genome-wide cross-cancer analysis illustrates the critical role of bimodal miRNA in patient survival and drug responses to PI3K inhibitors. | PLoS Comput Biol | 2022 | https://conductscience.org/library/papers/35639779 | PubMed |
| 12 | 25635347 | A new initiative on precision medicine. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25635347 | PubMed |
| 13 | 31298364 | MiR-93-5p promotes cervical cancer progression by targeting THBS2/MMPS signal pathway. | Eur Rev Med Pharmacol Sci | 2019 | https://conductscience.org/library/papers/31298364 | PubMed |
| 14 | 16895932 | COPA--cancer outlier profile analysis. | Bioinformatics | 2006 | https://conductscience.org/library/papers/16895932 | PubMed |
| 15 | 38510977 | Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: A review. | Comput Struct Biotechnol J | 2024 | https://conductscience.org/library/papers/38510977 | PubMed |
| 16 | 25605792 | limma powers differential expression analyses for RNA-sequencing and microarray studies. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25605792 | PubMed |
| 17 | 23591990 | Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines. | Hum Mol Genet | 2013 | https://conductscience.org/library/papers/23591990 | PubMed |
| 18 | 36324085 | GMMchi: gene expression clustering using Gaussian mixture modeling. | BMC Bioinformatics | 2022 | https://conductscience.org/library/papers/36324085 | PubMed |
| 19 | 31933762 | MiR-145 inhibits cervical cancer progression and metastasis by targeting WNT2B by Wnt/β-catenin pathway. | Int J Clin Exp Pathol | 2019 | https://conductscience.org/library/papers/31933762 | PubMed |
| 20 | 12011421 | Diagnosis of multiple cancer types by shrunken centroids of gene expression. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12011421 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42220006
GET https://conductscience.org/api/papers/v1/42220006/references?page=2